However, in colon cancer, Meding et al. (15) showed a strong association of GSTM3 expression with lymph node metastasis and cisplatin-treated metastatic colon cancer cells showed higher levels of GSTM3 than non-treated cells (23). The gene discussed is GSTM3; the disease is malignant colon neoplasm.